Henry Schein
(
HSIC
), a worldwide distributor of healthcare products and services,
recently entered into a distribution agreement with non-invasive
monitoring technology for patient care provider
Masimo Corporation
(
MASI
). Per the deal, the medical unit of Henry Schein, namely Henry
Schein Medical will distribute Masimo's Pronto-7, the only US Food
and Drug Administration (FDA) cleared small non-invasive device for
spot-checking of total hemoglobin (SpHb), SpO2, pulse rate and
perfusion index.
In addition to Pronto-7, Pronto with rainbow technology will
also be available from the US customer base of physician offices,
community health facilities, medical clinics, and ambulatory
surgical centers of HenrySchein.
Capable of measuring hemoglobin in less than a minute without
the needles risk compared to the hazards of traditional blood
tests, Pronto 7 is expected to go down well with the customer base
of Henry Schein. With several recent honors in its pocket including
2011 GOLD Medical Design Excellence Award
,
2011 TechAmerica High-Tech Innovation Award and the 2011 iF Product
Design Award, Pronto 7 is expected to add further life to Henry
Schein's medical business in the coming period.
Henry Schein's portfolio consists of consumable products, small
equipment, laboratory products, large dental and medical equipment,
equipment repair services, branded and generic pharmaceuticals,
vaccines, surgical products, diagnostic tests, infection-control
products and vitamins.
The company continues to experience strong top-line growth and
has established its footprint in both domestic and international
markets in dental, veterinary and medical supply
distribution. We are also encouraged by the company's focus on
improving its cost structure to drive profitability. The stock
retains a short-term Zacks #2 Rank (Buy).
Henry Schein's performance should improve further with the
gradual recovery in economic outlook. However, the company faces
stiff competition from major players like
McKesson Corporation
(
MCK
) and
Patterson Companies Inc.
(
PDCO
). Over the long term, we have a Neutral recommendation on the
stock.
HENRY SCHEIN IN (HSIC): Free Stock Analysis
Report
MASIMO CORP (MASI): Free Stock Analysis Report
MCKESSON CORP (MCK): Free Stock Analysis Report
PATTERSON COS (PDCO): Free Stock Analysis
Report
To read this article on Zacks.com click here.
Zacks Investment
Research